Clearwater Capital Partners Cyprus has sold 7,71,750 shares or 3.58% stake of Lyka Labs in the open market. With this, the consolidated shareholding of Clearwater Cyprus and Clearwater Singapore (Fund III) has reduced from 11.94% to 8.36%.
As on June 30, 2014, the promoters holding in the company stood at 23.30%, while institutions and non-institutions held 4.93% and 71.78% stake in the company, respectively.
Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.
